Observed hepatitis C virus (HCV) antibody prevalence for 16–49 year old males undergoing, or eligible to undergo, surgery
| Glasgow Royal Infirmary (16–49 years) | Stobhill General Hospital (16–49 years) | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Specialty group | Tested (Nm) | HCV positive (Hm) | Prevalence (%) | Tested (Nm) | HCV positive (Hm) | Prevalence (%) | Tested (Nm) | HCV positive (Hm) | Prevalence (%) |
| Hm, number of HCV antibody positive males aged 16–49 years; Nm, number of males aged 16–49 years HCV antibody tested. | |||||||||
| *Glasgow Royal Infirmary versus Stobhill General Hospital, NS. | |||||||||
| †General surgery versus orthopaedics, p=0.002 | |||||||||
| Cardiothoracic/ cardiology | 632 | 15 | 2.4 | 253 | 4 | 1.6 | 885 | 19 | 2.1 |
| Orthopaedics/rheumatology | 647 | 20 | 3.1 | 320 | 17 | 5.3 | 967 | 37 | 3.8 |
| General surgery/ENT | 679 | 43 | 6.3 | 171 | 4 | 2.3 | 850 | 47 | 5.5† |
| Total | 1958 | 78 | 4.0 | 744 | 25 | 3.4* | 2702 | 103 | 3.8 |